PPARA and hepatocellular carcinoma: Using H4IIEC3, a PPARα-responsive hepatoma cell line, we demonstrated that α-ESA reduced intracellular triglyceride accumulation by increasing mRNA concentrations and enzyme activity of PPARα target genes after 24 or 48 h of treatment [5].